SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-025907
Filing Date
2024-02-07
Accepted
2024-02-07 07:00:03
Documents
14
Period of Report
2024-02-07
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d694316d8k.htm   iXBRL 8-K 24160
  Complete submission text file 0001193125-24-025907.txt   150435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tngx-20240207.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tngx-20240207_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tngx-20240207_pre.xml EX-101.PRE 11707
15 EXTRACTED XBRL INSTANCE DOCUMENT d694316d8k_htm.xml XML 3766
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 24602087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)